"Severe Asthma 2019: Phenotyping in the Clinic and Selection of Therapies Across the Spectrum of Airway Diseases" on Oct. 11
Yale School of Medicine and Yale Center for Asthma and Airway Diseases invite you to attend the upcoming symposium, "Severe Asthma 2019: Phenotyping in the Clinic and Selection of Therapies Across the Spectrum of Airway Diseases", to be held on Friday, October 11, 2019, 8:00 AM - 4:00 PM, at the The Anlyan Center for Medical Research and Education (TAC) in New Haven, CT.
Living kidney donors face higher risk of hypertension
Compared with non-donors, living kidney donors face a higher risk of developing hypertension, which may have negative effects on their kidney function. The findings, which appear in an upcoming issue of CJASN, indicate the importance of preventing and managing hypertension in individuals who are kidney donors.
From the Chair’s [Standing] Desk –30% Fewer Internal Medicine Faculty Reported Burnout Symptoms in 2019
At the 9/16/19 faculty meeting, I highlighted our many accomplishments, provided information about our finances, celebrated faculty who had been promoted, and discussed plans for new programs and initiatives.
Lessons From the Field: How Practices Are Succeeding Under OCM
As rising drug costs continue to take up a larger portion of the total cost of care, practices in the Oncology Care Model find themselves in control of a shrinking portion of total costs, according to anecdotes from an academic medical center and a community-based practice during the National Comprehensive Cancer Network’s Policy Summit held September 12 in Washington, D.C.
FDA Grants Priority Review to Enfortumab Vedotin for Metastatic Urothelial Cancer
The FDA accepted the biologics license application (BLA) filing for the investigational agent enfortumab vedotin and granted a priority review for the agent to treat patients with locally advanced or metastatic urothelial cancer who have previously received a PD-1/L1 inhibitor and a platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.
For-profit dialysis center patients less likely to receive a transplant, study finds
Patients with renal failure who get dialysis at for-profit dialysis centers are less likely to receive a kidney transplant than patients who get dialysis at nonprofit centers, according to a study published Tuesday in JAMA.